Author:
Ho Soo Yei,Wang Weiling,Ng Fui Mee,Wong Yun Xuan,Poh Zhi Ying,Tan Sum Wai Eldwin,Ang Shi Hua,Liew Si Si,Joyner Wong Yin Sze,Tan Yvonne,Poulsen Anders,Pendharkar Vishal,Sangthongpitag Kanda,Manchester John,Basarab Gregory,Hill Jeffrey,Keller Thomas H.,Cherian Joseph
Funder
Agency for Science, Technology and Research (A*STAR) Biomedical Research Council core fund
Subject
Organic Chemistry,Drug Discovery,Pharmacology,General Medicine
Reference37 articles.
1. Clinical relevance of the ESKAPE pathogens;Pendleton;Expert. Rev. Anti Infect. Ther.,2013
2. The crisis of no new antibiotics-what is the way forward?;Piddock;Lancet Infect. Dis.,2012
3. 10 x '20 Progress--development of new drugs active against gram-negative bacilli: an update from the Infectious Diseases Society of America;Boucher;Clin. Infect. Dis.: An Official Publication of the Infectious Diseases Society of America,2013
4. Ceftolozane/Tazobactam (Zerbaxa) - a new intravenous antibiotic;Med. Lett. Drugs Ther.,2015
5. Ceftazidime/Avibactam (Avycaz) - a new intraveneous antibiotic;Med. Lett. Drugs Ther.,2015
Cited by
13 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献